Psychedelic Bulletin: Mindstate Design Labs Leaves Stealth Mode; No Synthetic Psilocybin...

Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights

PT292 – Sam Gandy – Vital Psychedelic Conversations

Psyence Group Announces DTC Eligibility Approval in the U.S.

Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004...

MYND Diagnostics Inc. Announces Participation in Approved Monash University (Australia) Government...

Mydecine’s Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in...

Mindset Pharma Appoints Dr. Fiona Randall as Senior Vice President of...

PT291 – Rick Tarnas & Sean Kelly, Ph.D. – The Impact...

Psyence Awarded ISO Certification through the British Standards Institute for its...

Load more